Providing tumor tissue samples during lung cancer surgery
Part of Cancer, Lungs & breathing clinical trials.
This study collects and analyzes tumor tissue from people with early-stage non-small cell lung cancer who are planning surgery. It may help researchers learn more about the cancer by studying samples taken at the time of your operation.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have non-small cell lung cancer (early stages such as stage I or II).
- Your cancer can be removed with surgery, and you plan to have the whole tumor removed.
- You will have a tumor tissue sample available at the time of your surgery.
- You must be able to receive care through the study sites/partner programs at specific Vanderbilt-related locations.
- You did not receive chemotherapy before surgery.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study enrolls adults who are being checked for possible lung cancer because of concerning symptoms or a high-risk situation. It aims to find molecular (cell/DNA-related) predictors that may help doctors better recognize lung cancer earlier.
This study looks at gene-related information from a lung tumor sample and pairs it with special imaging to better understand non-small cell lung cancer. If you have a confirmed diagnosis and the right samples/tests, this may help researchers match patients to the most useful information for planning treatment.
This study looks at molecular (biologic) signals in the tumor and nearby lymph nodes after curative surgery for stage IIIA lung cancer. It may help doctors better understand the disease and improve future treatment planning.
This study collects tumor tissue and related blood tests from people who already need a biopsy or surgery as part of their usual care. Researchers use the samples to learn what drives the tumor and how the tumor environment may affect treatment, which could help develop future therapies.
This study looks for specific genetic markers of lung cancer by testing tissue taken from a lung mass. It may help doctors detect and better understand lung cancer based on genetic clues.
This trial collects a small piece of your tumor right after it is removed during surgery. Researchers will study this tissue to learn more about cancer and how it responds to treatments.
Hear when a new Lung cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.